Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Institutional investors back Apiam to accelerate growth amid regional boom
    • News

    Institutional investors back Apiam to accelerate growth amid regional boom

    With it now abundantly clear that Australians who moved away from capital cities at the start of the pandemic have zero intention of returning to traffic jams and shoebox apartments, institutional investors have seen the light by backing regional vet operator Apiam Animal Health (ASX: AHX) to deliver on their ambitious regional expansion strategy.  Over

    Read More
    Public
  • Now you see me, ClearVue and Nodis powering glass for US Air Force
    • News

    Now you see me, ClearVue and Nodis powering glass for US Air Force

    ClearVue Technologies Ltd (ASX: CPV) and smart glass company Nodis Pte Ltd have signed a collaboration agreement to engineer an electronically controlled window solution for the US Air Force. The Companies have undertaken a first phase evaluation for the US Air Force at Tyndall Air Force Base in Florida trialling Nodis’ dynamic switchable glazing powered

    Read More
    Public
  • Cynata to tackle common transplant side effect with lead drug CYP-001
    • News

    Cynata to tackle common transplant side effect with lead drug CYP-001

    The first successful organ donation occurred in 1954 where a living donor gave a kidney to his identical twin. Since then, organ donation has become a routine practice with over 25,000 transplants conducted per year in US hospitals. Transplantation is far from simple, with an immense amount of preparation and aftercare required for recipients. A

    Read More
    Public
  • The key to happiness lies in your gut… No, really, just ask Microba
    • News

    The key to happiness lies in your gut… No, really, just ask Microba

    It’s no wonder that the health and wellness industry is worth over $4 trillion when you look at my bank statement. Perpetually on a health kick, I have been known to spend on gym memberships, protein powders, supplements, activewear and runners, and I’m not alone with many Aussies spending a serious chunk of cash on

    Read More
    Public
  • XTEK receives $9.5 million order for body armour in the US
    • News

    XTEK receives $9.5 million order for body armour in the US

    As discussions around gun violence in the United States continue, counter-market forces concurrently perforate through to the consumer market with defence products manufacturer XTEK receiving a $9.5 million order for body armour through their US-based armour division.  The purchase order comes from a customer that has elected to remain unnamed but will receive their $9.5m

    Read More
    Public
  • Nanollose’s bio-materials adopted into $500 billion textile industry
    • News

    Nanollose’s bio-materials adopted into $500 billion textile industry

    Contrary to what many think, cotton production is not great for the environment. Being one of the most popular materials, cotton is used in nearly half of all textile production and is known as the most profitable non-food crop globally. However, conventionally-grown cotton has proven insufficient for the planet because of its high water consumption

    Read More
    Public
  • «
  • ‹
  • 373
  • 374
  • 375
  • 376
  • 377
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.